Gates Frontier, Bezos Expeditions, Reliance Digital Health Limited, Greenoaks, Alumni Ventures, Moore Strategic Ventures, and Project X join ARCH as new additional investors
Ayúdame3D has become a leading social entity in social technology.
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
The company will submit an action plan on the observations and will engage with US FDA for next steps.
The investment will enable the company to enter European markets as well as enhance margins in current markets
The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy
The current ruling will assure the safety of the use of Ranitidine for Indian patients
EC grants conditional marketing authorization based on the EFFISAYIL trial
The yoga protocol included gentle and restorative yoga postures(asana) with regular periods of relaxation and pranayama
The hospital is being developed at a cost of more than Rs. 1,575 crore
Subscribe To Our Newsletter & Stay Updated
